Hexigone Inhibitors
PrivateLast Round
Seed
Jun 2, 2026
Total Funding Raised
$2.54M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Hexigone Inhibitors is an industrial chemicals company that develops and manufactures smart, sustainable anti-corrosion additives for the coatings industry.
Sector
Frontier & Industrial Tech
Verticals
Advanced Materials, Sustainable Materials, Clean Manufacturing, Circular Economy
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hexigone Inhibitors Comparables
Compare Hexigone Inhibitors with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SynMatter | 79% | |
| Grace Inc. | 77% | |
| ICL Group | 76% | |
Hexigone Inhibitors Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 2, 2026 | ||||
| Grant | Jun 2, 2026 | ||||
| VC Round | Apr 30, 2024 | ||||
| Grant | Oct 28, 2019 | ||||
| Debt | Feb 1, 2018 |
Key People
Founding team and executive leadership
Hexigone Inhibitors Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACF Investors | VC Round |
| Royal Society of Chemistry | Grant |
| UK Innovation & Science Seed Fund | Seed |
| Royal Academy of Engineering | Grant |
| Waterspring Ventures | VC Round |
| Oxford Innovation Finance | VC Round |
| Development Bank of Wales | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 186% MoM, reaching 1.7K.
- Jun 1, 2025
Monthly visitors grew 215% MoM, reaching 1.3K.
Hexigone Inhibitors Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hexigone Inhibitors's valuation, stock price, and market status.